Effects of recombinant human endostatin on peritoneal angiogenesis in peritoneal dialysis rats

Nephrology

Volumn 16, Issue 6, 2011, Pages 599-606

  Zhao, Zhan Zheng ^a   Cao, Ying ^a   Liu, Zhang Suo ^a   Xiao, Jing ^a   Tang, Lin ^a   Wang, Pei ^a   Liang, Xian Hui ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

angiogenesis; basic fibroblast growth factor; microvessel density; peritoneal dialysis; recombinant human endostatin; vascular endothelial growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD34 ANTIGEN; CREATININE; ENDOSTAR; MESSENGER RNA; NITROGEN; RECOMBINANT ENDOSTATIN; UNCLASSIFIED DRUG; UREA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSATE; DOSE RESPONSE; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; MALE; NEPHRECTOMY; NONHUMAN; PERITONEAL DIALYSIS; PERITONEUM; PERITONEUM ANGIOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UREA NITROGEN BLOOD LEVEL; UREMIA;

ANGIOGENESIS INHIBITORS; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOSTATINS; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; MALE; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; NEPHRECTOMY; PERITONEAL DIALYSIS; PERITONEUM; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; UREMIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80051706212     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2011.01465.x     Document Type: Article

References (16)

1. Margetts PJ, Gyorffy S, Kolb M, et al,. Antiangiogenic and antifibroticgene therapy in a chronic infusion model of peritoneal dialysis in rats. J. Am. Soc. Nephrol. 2002; 13: 721-8. (Pubitemid 34183938)
2. Van Westrhenen R, Zweers MM, Kunne C, et al,. A pyruvate-buffered dialysis fluid induces less peritoneal angiogenesis and fibrosis than a conventional solution. Perit. Dial. Int. 2008; 28: 487-96.
3. Krediet RT,. Evaluation of peritoneal membrane integrity. J. Nephrol. 1997; 10: 238-44. (Pubitemid 27465857)
4. Parikova A, Smit W, Struijk DG, et al,. Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure. Kidney Int. 2006; 70: 1988-94. (Pubitemid 44863388)
5. Margetts PJ, Gyorffy S, Kolb M, et al,. Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J. Am. Soc. Nephrol. 2002; 13: 721-8. (Pubitemid 34183938)
6. Bellini MH, Coutinho EL, Filgueiras TC, et al,. Endostatin expression in the murine model of ischaemia/reperfusion-induced acute renal failure. Nephrology (Carlton) 2007; 12: 459-65. (Pubitemid 47366650)
7. Weidner N,. Intratumor microvessel density as prognostic factor in cancer. Am. J. Pathol. 1995; 147: 9-19.
8. Mlambo NC, Hylander B, Brauner A,. Increased levels of transforming growth factor beta 1 and basic fibroblast growth factor in patients on CAPD: A study during non-infected steady state and peritonitis. Inflammation 1999; 23: 131-9. (Pubitemid 29178601)
9. Yang WS, Tsai TJ, Shih CL, et al,. Intraperitoneal vascular endothelial growth factor C level is related to peritoneal dialysis ultrafiltration. Blood Purif. 2009; 28: 69-74.
10. Yuan J, Fang W, Ni Z, et al,. Association of peritoneal angiogenesis with angiopoietin-2 in peritoneal dialysis rats. Chin. J. Nephrol. 2009; 25: 415-9.
11. Yu Q, Zhao D, Yao J, et al,. High glucose and uremic serum affect the expression of VEGF in human peritoneal mesothelial cell. Chin. J. Blood Purif. 2005; 4: 379-92.
12. Stompór T, Zdzienicka A, Motyka M, et al,. Selected growth factors in peritoneal dialysis: Their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport. Perit. Dial. Int. 2002; 22: 670-6. (Pubitemid 36131496)
13. Ray P, Acheson D, Chitrakar R, et al,. Basic fibroblast growth factor among children with diarrhea-associated hemolytic uremic syndrome. J. Am. Soc. Nephrol. 2002; 13 (3): 699-707. (Pubitemid 34183935)
14. Zhao Z, Liu Z, Liang X, et al,. Expression and significance of aquaporin and basic fibroblast growth factor in human peritoneal mesothelial cells. Chin. J. Nephrol. 2008; 24: 669-70.
15. Tanabe K, Maeshima Y, Ichinose K, et al,. Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model. Kidney Int. 2007; 71: 227-38. (Pubitemid 46160923)
16. Piatrouskaya NA, Kharuzhyk SA, Vozmitel MA, et al,. Experimental study of antiangiogenic and photodynamic therapies combination for treatment of peritoneal carcinomatosis: Preliminary results. Exp. Oncol. 2010; 32: 100-3.